Your browser doesn't support javascript.
loading
Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer.
de Leeuw, Simon P; Pruis, Melinda A; Sikkema, Barend J; Mohseni, Mostafa; Veerman, G D Marijn; Paats, Marthe S; Dumoulin, Daphne W; Smit, Egbert F; Schols, Annemie M W J; Mathijssen, Ron H J; van Rossum, Elisabeth F C; Dingemans, Anne-Marie C.
Affiliation
  • de Leeuw SP; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Pruis MA; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Sikkema BJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Mohseni M; Department of Internal Medicine, Division of Endocrinology and Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Veerman GDM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Paats MS; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Dumoulin DW; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Smit EF; Department of Pulmonary Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Schols AMWJ; School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van Rossum EFC; Department of Internal Medicine, Division of Endocrinology and Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: a.dingemans@erasmusmc.nl.
J Thorac Oncol ; 18(8): 1017-1030, 2023 08.
Article in En | MEDLINE | ID: mdl-37001858
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Sarcopenia / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Thorac Oncol Year: 2023 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Sarcopenia / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Thorac Oncol Year: 2023 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos